Home
BIAF
BIAF News

Latest bioAffinity Technologies Inc. (BIAF) News on July 27, 2024

Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESSWIRE

14 days ago

Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung

Business Wire

18 days ago

bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung

BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESSWIRE

21 days ago

BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests

Business Wire

a month ago

bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests

bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes

Business Wire

2 months ago

bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes

bioAffinity Technologies News Update

Business Wire

3 months ago

bioAffinity Technologies News Update

bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth

Business Wire

3 months ago

bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth

bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening

Business Wire

4 months ago

bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening

bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results

Business Wire

4 months ago

bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results

Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement

PR Newswire

5 months ago

Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement

bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

Business Wire

5 months ago

bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement

PR Newswire

5 months ago

WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement

bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

Business Wire

5 months ago

bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung

Business Wire

5 months ago

bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung

Here's Why We're A Bit Worried About bioAffinity Technologies' (NASDAQ:BIAF) Cash Burn Situation

Simply Wall St.

5 months ago

Here's Why We're A Bit Worried About bioAffinity Technologies' (NASDAQ:BIAF) Cash Burn Situation

bioAffinity Technologies News Update

Business Wire

5 months ago

bioAffinity Technologies News Update

Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice

Business Wire

6 months ago

Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice

bioAffinity Technologies In The News

Business Wire

6 months ago

bioAffinity Technologies In The News

BM Technologies (BMTX) Champions Campus Excellence and Announces 2023 ACE Award and Partnership Winners

ACCESSWIRE

6 months ago

BM Technologies (BMTX) Champions Campus Excellence and Announces 2023 ACE Award and Partnership Winners

Genius Group and FatBrain AI Agree to Merge into Growth Platform to Accelerate the Exponential Economy of Tomorrow

GlobeNewswire

6 months ago

Genius Group and FatBrain AI Agree to Merge into Growth Platform to Accelerate the Exponential Economy of Tomorrow

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer

Business Wire

6 months ago

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer

Orion (OESX) Preliminary Q3 Results Depict Strong Demand

Zacks

6 months ago

Orion (OESX) Preliminary Q3 Results Depict Strong Demand

MAIA Soars 20% on Interim Results From Lung Cancer Study

Zacks

6 months ago

MAIA Soars 20% on Interim Results From Lung Cancer Study

MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024

Business Wire

6 months ago

MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024

Glen Burnie Bancorp's (NASDAQ:GLBZ) Dividend Will Be $0.10

Simply Wall St.

6 months ago

Glen Burnie Bancorp's (NASDAQ:GLBZ) Dividend Will Be $0.10

VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo

GlobeNewswire

7 months ago

VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo

The Container Store lowers Q3 sales guidance

Retail Dive

7 months ago

The Container Store lowers Q3 sales guidance

bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

ACCESSWIRE

7 months ago

bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors

GlobeNewswire

7 months ago

VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors

3 Penny Stocks to Make You the Millionaire Next Door: 2024 Edition

InvestorPlace

7 months ago

3 Penny Stocks to Make You the Millionaire Next Door: 2024 Edition

Pacira Appoints Frank D. Lee as Chief Executive Officer

GlobeNewswire

7 months ago

Pacira Appoints Frank D. Lee as Chief Executive Officer

Innovative Solutions and Support Inc (ISSC) Reports Strong Q4 and Full Year Fiscal 2023 Results

GuruFocus.com

7 months ago

Innovative Solutions and Support Inc (ISSC) Reports Strong Q4 and Full Year Fiscal 2023 Results

PodcastOne (NASDAQ: PODC) Acquires Exclusive Rights to Hit Podcast Was I In A Cult? From Hosts Liz Iacuzzi and Tyler Measom

GlobeNewswire

7 months ago

PodcastOne (NASDAQ: PODC) Acquires Exclusive Rights to Hit Podcast Was I In A Cult? From Hosts Liz Iacuzzi and Tyler Measom

Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis

GlobeNewswire

7 months ago

Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis

Pleasing Signs As A Number Of Insiders Buy GeneDx Holdings Stock

Simply Wall St.

7 months ago

Pleasing Signs As A Number Of Insiders Buy GeneDx Holdings Stock

Kustom Entertainment Inc. and Clover Leaf Capital Corp. Amend the Lock-Up Agreement in their Proposed Business Combination

GlobeNewswire

7 months ago

Kustom Entertainment Inc. and Clover Leaf Capital Corp. Amend the Lock-Up Agreement in their Proposed Business Combination

Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference Call

ACCESSWIRE

8 months ago

Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference Call

Lead Real Estate Co., Ltd Announces Sale of 17-unit Luxury Condominium in Tokyo

GlobeNewswire

8 months ago

Lead Real Estate Co., Ltd Announces Sale of 17-unit Luxury Condominium in Tokyo

bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors

Business Wire

8 months ago

bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors

Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®

GlobeNewswire

8 months ago

Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®

GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy

GlobeNewswire

8 months ago

GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy

Down -38.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Trevi Therapeutics, Inc. (TRVI)

Zacks

8 months ago

Down -38.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Trevi Therapeutics, Inc. (TRVI)

ACCESSWIRE

8 months ago

Vivakor Reports 39% Revenue Growth to $16.3 Million Revenue for Third Quarter 2023

CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024

Business Wire

8 months ago

CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

Business Wire

8 months ago

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

Old Point Financial Corporation Declares Quarterly Dividend

PR Newswire

8 months ago

Old Point Financial Corporation Declares Quarterly Dividend

Lead Real Estate Co., Ltd Reports Fiscal 2023 Year-end Financial Results

GlobeNewswire

8 months ago

Lead Real Estate Co., Ltd Reports Fiscal 2023 Year-end Financial Results

CPI Aerostructures Receives $4.4M Orders from Embraer for Engine Inlet Assemblies

GlobeNewswire

8 months ago

CPI Aerostructures Receives $4.4M Orders from Embraer for Engine Inlet Assemblies

Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference

PR Newswire

8 months ago

Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference

ACCESSWIRE

8 months ago

Vivakor Announces Results of Special Meeting of Shareholders with All Proposals Approved with Greater than 90% Voted For Each Proposal

Farmer Bros (NASDAQ:FARM) investors are sitting on a loss of 89% if they invested five years ago

Simply Wall St.

8 months ago

Farmer Bros (NASDAQ:FARM) investors are sitting on a loss of 89% if they invested five years ago

bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening

Business Wire

8 months ago

bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

Business Wire

8 months ago

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

Trevi Therapeutics, Inc. (TRVI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Zacks

8 months ago

Trevi Therapeutics, Inc. (TRVI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Individual investors account for 54% of Genenta Science S.p.A.'s (NASDAQ:GNTA) ownership, while insiders account for 30%

Simply Wall St.

8 months ago

Individual investors account for 54% of Genenta Science S.p.A.'s (NASDAQ:GNTA) ownership, while insiders account for 30%

Hour Loop Reports Third Quarter 2023 Results

GlobeNewswire

8 months ago

Hour Loop Reports Third Quarter 2023 Results

Heritage Global Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Simply Wall St.

8 months ago

Heritage Global Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Achieve Life Sciences Inc Earnings Call

Smart Sand, Inc. (NASDAQ:SND) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Smart Sand, Inc. (NASDAQ:SND) Q3 2023 Earnings Call Transcript

Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023

GlobeNewswire

9 months ago

Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023

ACCESSWIRE

9 months ago

Vivakor Issues Shareholder Update

Share on Social Networks: